Cure trends in acute lymphoblastic leukemia: is it time for a revised concept of cure?

Por Zwaan, Christian Michel, Sposto, Richard
Publicado em 2013

Improving Access To Novel Agents For Childhood Leukemia

Por Sun, Weili, Gaynon, Paul S., Sposto, Richard, Wayne, Alan S.
Publicado no Cancer (2015)

Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B cell lineage acute lymphoblastic leukemia

Por Gruber, Tanja Andrea, Chang, Mi Sook, Sposto, Richard, Müschen, Markus
Publicado em 2010

LG-65 CLINICOPATHOLOGICAL FEATURES AND OUTCOME IN ADOLESCENTS/YOUNG ADULTS (AYA) WITH LOW GRADE GLIOMA (LGG) COMPARED WITH CHILDREN: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

Por Margol, Ashley, Xia, Caihong, Sposto, Richard, Freyer, David, Dhall, Girish
Publicado no Neuro Oncol (2016)

MB-101 TOXICITY AND OUTCOME IN ADOLESCENT AND YOUNG ADULTS (AYA) TREATED FOR MEDULLOBLASTOMA (MB) AND PRIMITIVE NEUROECTODERMAL TUMORS (PNET) ON COG-A9961 AND CCG-99701: A REPORT F...

Por Farzingohar, Shadi, Xia, Caihong, Sposto, Richard, Freyer, David, Dhall, Girish
Publicado no Neuro Oncol (2016)

A Phase I Study Of Oxaliplatin And Doxorubicin In Pediatric Patients With Relapsed Or Refractory Extracranial Non-Hematopoietic Solid Tumors

Por Mascarenhas, Leo, Malogolowkin, Marcio, Armenian, Saro H., Sposto, Richard, Venkatramani, Rajkumar
Publicado em 2013

A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors

Por Venkatramani, Rajkumar, Malogolowkin, Marcio, Davidson, Tom B., May, William, Sposto, Richard, Mascarenhas, Leo
Publicado em 2013

A GALECTIN-3-DEPENDENT PATHWAY UPREGULATES INTERLEUKIN-6 IN THE MICROENVIRONMENT OF HUMAN NEUROBLASTOMA

Por Silverman, Ayaka M., Nakata, Rie, Shimada, Hiroyuki, Sposto, Richard, DeClerck, Yves A.
Publicado em 2012

Shortened Intensified Multiagent Chemotherapy And Non-Cross Resistant Maintenance Therapy For Advanced Lymphoblastic Lymphoma In Children And Adolescents: Report from the Children’...

Por Abromowitch, Minnie, Sposto, Richard, Perkins, Sherrie, Zwick, David, Siegel, Stuart, Finlay, Jonathan, Cairo, Mitchell S.
Publicado em 2008

Molecular and Clinical Diagnosis of Group A Streptococcal Pharyngitis in Children

Por Felsenstein, Susanna, Faddoul, Diala, Sposto, Richard, Batoon, Kristine, Polanco, Claudia M., Dien Bard, Jennifer
Publicado no J Clin Microbiol (2014)

NU-12 THE USE OF AROMATHERAPY TO REDUCE CHEMOTHERAPY-INDUCED NAUSEA IN CHILDREN WITH CANCER; A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL

Por Evans, Anna, Garretson, Cassie, Pedroja, Eliza, Malvar, Jemily, Margol, Ashley, Sposto, Richard, Nelson, Mary Baron
Publicado no Neuro Oncol (2016)

Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy

Por Orgel, Etan, Mueske, Nicole M, Sposto, Richard, Gilsanz, Vicente, Freyer, David R, Mittelman, Steven D
Publicado no Leuk Lymphoma (2016)

Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Por Orgel, Etan, Sposto, Richard, Malvar, Jemily, Seibel, Nita L., Ladas, Elena, Gaynon, Paul S., Freyer, David R.
Publicado em 2014

Escalation of Oncologic Services at the End of Life Among Patients With Gynecologic Cancer at an Urban, Public Hospital

Por Wu, Eijean, Rogers, Anna, Ji, Lingyun, Sposto, Richard, Church, Terry, Roman, Lynda, Tripathy, Debu, Lin, Yvonne G.
Publicado no J Oncol Pract (2015)

Metabolism of diffuse intrinsic brainstem gliomas in children

Por Panigrahy, Ashok, Nelson, Marvin D., Finlay, Jonathan L., Sposto, Richard, Krieger, Mark D., Gilles, Floyd H., Blüml, Stefan
Publicado em 2008

Intensive Chemotherapy for Systemic Anaplastic Large Cell Lymphoma in Children and Adolescents: Final Results of Children's Cancer Group Study 5941

Por Lowe, Eric J., Sposto, Richard, Perkins, Sherrie L., Gross, Thomas G., Finlay, Jonathan, MD, David Zwick, Abromowitch, Minnie
Publicado em 2009

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

Por Kelly, Kara M., Sposto, Richard, Hutchinson, Raymond, Massey, Vickie, McCarten, Kathleen, Perkins, Sherrie, Lones, Mark, Villaluna, Doojduen, Weiner, Michael
Publicado em 2011

Nuclear factor IA is expressed in astrocytomas and is associated with improved survival

Por Song, Hae-Ri, Gonzalez-Gomez, Ignacio, Suh, Greg S., Commins, Deborah L., Sposto, Richard, Gilles, Floyd H., Deneen, Benjamin, Erdreich-Epstein, Anat
Publicado em 2010

Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy

Por Liu, Yin, Wu, Hong-Wei, Sheard, Michael A., Sposto, Richard, Somanchi, Srinivas S., Cooper, Laurence J.N., Lee, Dean A., Seeger, Robert C.
Publicado em 2013

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the ea...

Por Patte, Catherine, Auperin, Anne, Gerrard, Mary, Michon, Jean, Pinkerton, Ross, Sposto, Richard, Weston, Claire, Raphael, Martine, Perkins, Sherrie L., McCarthy, Keith, Cairo, Mitchell S.
Publicado em 2007